Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iHIVARNA-01 in Chronically HIV-infected Patients
NCT02888756Phase 2Terminated
- Start
- Apr 2017
- Primary completion
- Feb 2018
- Modality
- Prophylactic Vaccines, DNA Vaccines, mRNA Therapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of iHIVARNA-01 in human immunodeficiency virus infection (HIV). Started Apr 2017; status: terminated.
02
Drugs
iHIVARNA-01
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02888756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02888756.